- Home
- MRNA vs HST Comparison
MRNA vs HST Comparison
Compare MRNA & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | HST |
|---|---|---|
| Founded | 2010 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 11.9B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | HST |
|---|---|---|
| Price | $27.74 | $17.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $33.91 | $18.65 |
| AVG Volume (30 Days) | ★ 9.9M | 7.6M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 5.21% |
| EPS Growth | N/A | ★ 3.27 |
| EPS | N/A | ★ 1.06 |
| Revenue | $2,232,000,000.00 | ★ $5,950,000,000.00 |
| Revenue This Year | N/A | $6.31 |
| Revenue Next Year | $0.77 | $1.80 |
| P/E Ratio | ★ N/A | $16.31 |
| Revenue Growth | N/A | ★ 6.44 |
| 52 Week Low | $22.28 | $12.22 |
| 52 Week High | $48.92 | $19.37 |
Technical Indicators
Market Signals| Indicator | MRNA | HST |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 50.20 |
| Support Level | $23.92 | $17.09 |
| Resistance Level | $26.00 | $17.69 |
| Average True Range (ATR) | 1.29 | 0.37 |
| MACD | 0.32 | -0.04 |
| Stochastic Oscillator | 99.82 | 43.53 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.